Chitosan-Hydroxypropyl Methylcellulose Matrices as Carriers for Hydrodynamically Balanced Capsules of Moxifloxacin HCl
- PMID: 27142106
- DOI: 10.2174/1567201813666160504100842
Chitosan-Hydroxypropyl Methylcellulose Matrices as Carriers for Hydrodynamically Balanced Capsules of Moxifloxacin HCl
Abstract
Background: In recent years, gastroretentive, hydrodynamically balanced system (HBS) for stomach-specific floating sustained drug release has gained a lot of importance in improving absorption of drugs especially those absorbed from stomach and small intestine.
Objective: The objective of the current investigation is to evaluate chitosan-hydroxypropyl methylcellulose (HPMC) based on polymeric matrices as a carrier for single-unit capsules based on HBS for stomach- specific floating sustained drug release using moxifloxacin HCl (MX) as a model drug.
Method: Various HBS capsules of MX were prepared by physical blending of MX with chitosan (low or medium molecular mass) or HPMC (K4M or K15M) or chitosan-HPMC combinations in varying proportions followed by encapsulation into size 0 capsules made of hard gelatin. The in vitro buoyancy and drug release in 0.1 N HCl (pH 1.2) were evaluated.
Results: HBS capsules based on chitosan (low and medium molecular weight and their combination) as polymer matrix failed to float on 0.1 N HCl (pH 1.2). Whereas, formulations containing HPMC (K4M or K15M) or their mixture with chitosan, remained buoyant and released MX over 9 h in the acidic dissolution medium following zero-order kinetics.
Conclusion: HPMC (K4M, K15M, blend of K4M and K15M) or their mixture with low/medium molecular mass chitosan may constitute excellent carrier systems for the stomach-specific sustained delivery of MX over a longer period.
Keywords: Chitosan; HPMC; drug release; hydrodynamically balanced system.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.
Similar articles
-
Low molecular mass chitosan as carrier for a hydrodynamically balanced system for sustained delivery of ciprofloxacin hydrochloride.Acta Pharm. 2012 Jun;62(2):237-50. doi: 10.2478/v10007-012-0013-2. Acta Pharm. 2012. PMID: 22750821
-
The macromolecular polymers for the preparation of hydrodynamically balanced systems--methods of evaluation.Drug Dev Ind Pharm. 2004;30(9):947-57. doi: 10.1081/ddc-200037179. Drug Dev Ind Pharm. 2004. PMID: 15554219
-
The effect of pH and ionic strength of dissolution media on in-vitro release of two model drugs of different solubilities from HPMC matrices.Colloids Surf B Biointerfaces. 2013 Nov 1;111:384-91. doi: 10.1016/j.colsurfb.2013.06.034. Epub 2013 Jun 25. Colloids Surf B Biointerfaces. 2013. PMID: 23850747
-
Hydrogel Delivery Systems for Biological Active Substances: Properties and the Role of HPMC as a Carrier.Molecules. 2025 Mar 18;30(6):1354. doi: 10.3390/molecules30061354. Molecules. 2025. PMID: 40142128 Free PMC article. Review.
-
The use of hypromellose in oral drug delivery.J Pharm Pharmacol. 2005 May;57(5):533-46. doi: 10.1211/0022357055957. J Pharm Pharmacol. 2005. PMID: 15901342 Review.
Cited by
-
pH stimuli-responsive hydrogels from non-cellulosic biopolymers for drug delivery.Front Bioeng Biotechnol. 2023 Sep 12;11:1270364. doi: 10.3389/fbioe.2023.1270364. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 37781530 Free PMC article. Review.
-
Gastric floating tablet improves the bioavailability and reduces the hypokalemia effect of gossypol in vivo.Saudi Pharm J. 2021 Apr;29(4):305-314. doi: 10.1016/j.jsps.2021.03.001. Epub 2021 Mar 14. Saudi Pharm J. 2021. PMID: 33994825 Free PMC article.
-
Hyaluronate Nanoparticles as a Delivery System to Carry Neuroglobin to the Brain after Stroke.Pharmaceutics. 2020 Jan 3;12(1):40. doi: 10.3390/pharmaceutics12010040. Pharmaceutics. 2020. PMID: 31947806 Free PMC article.
-
Applications of nanomaterials in tissue engineering.RSC Adv. 2021 May 26;11(31):19041-19058. doi: 10.1039/d1ra01849c. eCollection 2021 May 24. RSC Adv. 2021. PMID: 35478636 Free PMC article. Review.
-
Gastroretentive Technologies in Tandem with Controlled-Release Strategies: A Potent Answer to Oral Drug Bioavailability and Patient Compliance Implications.Pharmaceutics. 2021 Sep 30;13(10):1591. doi: 10.3390/pharmaceutics13101591. Pharmaceutics. 2021. PMID: 34683884 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources